Please Wait.....
Report
Connected Drug Delivery Devices Market By Type (Injectable, Inhalation Devices), By Technology (Bluetooth, NFC, Others), By End-use (Homecare, Hospitals): Global Opportunity Analysis and Industry Forecast, 2021-2030
Market Report I 2022-08-01 I 210 Pages I Allied Market Research
The global connected drug delivery devices market is envisioned to garner $2,095.2 million by 2030, growing from $290.3 million in 2021 at a CAGR of 24.29% from 2022 to 2030.
Connected drug delivery devices are integrated with capabilities that include connectivity to a wide range of digital services. These devices are being developed by various market players with an aim to support superior patient supervision and counselling. Connected drug delivery devices are equipped with several features, such as adherence trackers, dosing remainders, and patient diaries to collect health information. These devices are prominently used in the treatment of asthma, Chronic Obstructive Pulmonary Disease (COPD), diabetes, and other cardiovascular disorders.
The efficiency of drug delivery devices in therapeutic procedures along with rising usage of electronic healthcare devices are anticipated to fuel market expansion for connected drug delivery devices over the forecast period. In addition to this, it is projected that an increase in the prevalence of diabetes, COPD, and asthma will offer a lucrative potential for increasing use of connected drug delivery devices throughout the course of the forecast period.
On the other hand, high cost associated with the research and development proficiencies, limited infrastructural facilities, and imposition of stringent regulations on drug delivery systems are expected to hinder the market growth. Also, lack of favorable reimbursement scenario and technology penetration in the developing economies, availability of low-cost substitutes, and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period.
Furthermore, increased public-private funding for targeted research initiatives, rising air pollution levels, and an increase in product innovations and development due to global technological breakthroughs will all create lucrative opportunities for key players in the market throughout the projection period. In the future, the market growth rate will be accelerated due to expanding number of strategic alliances, increasing Internet usage, increasing number of hospitals and laboratories, and rising per-capita expenditure on health care spending. For instance, in February 2022, Aptar Pharma, a global leader in drug delivery systems launched a product Hero Tracker Sense, which is a next generation Metered-Dose Inhaler (MDI) add-on connected device, designed to address patient inhalation technique and adherence. It is designed to help improve the lives of patients around the world suffering from chronic respiratory diseases such as asthma, COPD, cystic fibrosis, and other respiratory conditions caused by COVID-19, to track their MDI usage and facilitate improved adherence to their prescribed therapy.
Global distribution and sales channel disruption due to COVID-19 pandemic could be blamed for the decline in connected drug delivery devices sales. People had to face restrictions such as lockdown, social distancing, and others. During the pandemic, business processes such as production, inventory management, and distribution of goods and services have ceased, which is expected to have a significant impact on the worldwide economy. However, the coronavirus outbreak made the high demand for simple and secure homecare setting medical devices. A healthcare provider is now able to remotely monitor a patient's medicine due to the requirement for online connectivity equipment. Owing to these factors, the COVID-19 pandemic's negative effects were decreased and the market kept expanding gradually.
The key players profiled in the connected drug delivery devices market report include Adherium, BD, Proteus Digital Health, propeller Health, F. Hoffmann-La Roche Ltd, Ypsomed AG, Cohero Health, Inc., West Pharmaceutical Services, Syncro Technology Corp., and AptarGroup Inc.
Key Benefits For Stakeholders
-This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the connected drug delivery devices market analysis from 2021 to 2030 to identify the prevailing connected drug delivery devices market opportunities.
-The market research is offered along with information related to key drivers, restraints, and opportunities.
-Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
-In-depth analysis of the connected drug delivery devices market segmentation assists to determine the prevailing market opportunities.
-Major countries in each region are mapped according to their revenue contribution to the global market.
-Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
-The report includes the analysis of the regional as well as global connected drug delivery devices market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
Injectable Devices
Inhalation Devices
Others
By Technology
NFC
Bluetooth
Others
ByEnd-user
Homecare settings
Hospitals
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
United Arab Emirates
South Africa
Rest of LAMEA
List of Key Players Profiled in the Report
Adherium
BD
Proteus Digital Health
propeller Health
F. Hoffmann-La Roche Ltd
Ypsomed AG
Cohero Health, Inc.
West Pharmaceutical Services, Inc.
Syncro Technology Corp.
AptarGroup Inc.
Key Market Segments
By Type
- Injectable
- Inhalation Devices
By Technology
- Bluetooth
- NFC
- Others
By End-use
- Homecare
- Hospitals
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest Of Asia Pacific
- LAMEA
- Brazil
- Saudi Arabia
- UAE
- South Africa
- Rest of LAMEA
- Key Market Players
- Adherium
- BD
- Proteus Digital Health
- PROPELLER HEALTH
- F. Hoffmann-La Roche Ltd
- Ypsomed AG
- Cohero Health, Inc.
- West Pharmaceutical Services, Inc.
- Syncro Technology Corp.
- AptarGroup Inc.
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter's five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
3.7.Regulatory Guidelines
3.8.Value Chain Analysis
3.9.Market Share Analysis
3.10.Key Regulation Analysis
3.11.Patent Landscape
CHAPTER 4: CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2 Injectable
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.3 Inhalation Devices
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
CHAPTER 5: CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY
5.1 Overview
5.1.1 Market size and forecast
5.2 Bluetooth
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.3 NFC
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
5.4 Others
5.4.1 Key market trends, growth factors and opportunities
5.4.2 Market size and forecast, by region
5.4.3 Market analysis by country
CHAPTER 6: CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE
6.1 Overview
6.1.1 Market size and forecast
6.2 Homecare
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Hospitals
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
CHAPTER 7: CONNECTED DRUG DELIVERY DEVICES MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Type
7.2.3 North America Market size and forecast, by Technology
7.2.4 North America Market size and forecast, by End-use
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Market size and forecast, by Type
7.2.5.1.2 Market size and forecast, by Technology
7.2.5.1.3 Market size and forecast, by End-use
7.2.5.2 Canada
7.2.5.2.1 Market size and forecast, by Type
7.2.5.2.2 Market size and forecast, by Technology
7.2.5.2.3 Market size and forecast, by End-use
7.2.5.3 Mexico
7.2.5.3.1 Market size and forecast, by Type
7.2.5.3.2 Market size and forecast, by Technology
7.2.5.3.3 Market size and forecast, by End-use
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Type
7.3.3 Europe Market size and forecast, by Technology
7.3.4 Europe Market size and forecast, by End-use
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Market size and forecast, by Type
7.3.5.1.2 Market size and forecast, by Technology
7.3.5.1.3 Market size and forecast, by End-use
7.3.5.2 United Kingdom
7.3.5.2.1 Market size and forecast, by Type
7.3.5.2.2 Market size and forecast, by Technology
7.3.5.2.3 Market size and forecast, by End-use
7.3.5.3 France
7.3.5.3.1 Market size and forecast, by Type
7.3.5.3.2 Market size and forecast, by Technology
7.3.5.3.3 Market size and forecast, by End-use
7.3.5.4 Spain
7.3.5.4.1 Market size and forecast, by Type
7.3.5.4.2 Market size and forecast, by Technology
7.3.5.4.3 Market size and forecast, by End-use
7.3.5.5 Italy
7.3.5.5.1 Market size and forecast, by Type
7.3.5.5.2 Market size and forecast, by Technology
7.3.5.5.3 Market size and forecast, by End-use
7.3.5.6 Rest of Europe
7.3.5.6.1 Market size and forecast, by Type
7.3.5.6.2 Market size and forecast, by Technology
7.3.5.6.3 Market size and forecast, by End-use
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Type
7.4.3 Asia-Pacific Market size and forecast, by Technology
7.4.4 Asia-Pacific Market size and forecast, by End-use
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Market size and forecast, by Type
7.4.5.1.2 Market size and forecast, by Technology
7.4.5.1.3 Market size and forecast, by End-use
7.4.5.2 Japan
7.4.5.2.1 Market size and forecast, by Type
7.4.5.2.2 Market size and forecast, by Technology
7.4.5.2.3 Market size and forecast, by End-use
7.4.5.3 India
7.4.5.3.1 Market size and forecast, by Type
7.4.5.3.2 Market size and forecast, by Technology
7.4.5.3.3 Market size and forecast, by End-use
7.4.5.4 South Korea
7.4.5.4.1 Market size and forecast, by Type
7.4.5.4.2 Market size and forecast, by Technology
7.4.5.4.3 Market size and forecast, by End-use
7.4.5.5 Australia
7.4.5.5.1 Market size and forecast, by Type
7.4.5.5.2 Market size and forecast, by Technology
7.4.5.5.3 Market size and forecast, by End-use
7.4.5.6 Rest Of Asia Pacific
7.4.5.6.1 Market size and forecast, by Type
7.4.5.6.2 Market size and forecast, by Technology
7.4.5.6.3 Market size and forecast, by End-use
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Type
7.5.3 LAMEA Market size and forecast, by Technology
7.5.4 LAMEA Market size and forecast, by End-use
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Market size and forecast, by Type
7.5.5.1.2 Market size and forecast, by Technology
7.5.5.1.3 Market size and forecast, by End-use
7.5.5.2 Saudi Arabia
7.5.5.2.1 Market size and forecast, by Type
7.5.5.2.2 Market size and forecast, by Technology
7.5.5.2.3 Market size and forecast, by End-use
7.5.5.3 UAE
7.5.5.3.1 Market size and forecast, by Type
7.5.5.3.2 Market size and forecast, by Technology
7.5.5.3.3 Market size and forecast, by End-use
7.5.5.4 South Africa
7.5.5.4.1 Market size and forecast, by Type
7.5.5.4.2 Market size and forecast, by Technology
7.5.5.4.3 Market size and forecast, by End-use
7.5.5.5 Rest of LAMEA
7.5.5.5.1 Market size and forecast, by Type
7.5.5.5.2 Market size and forecast, by Technology
7.5.5.5.3 Market size and forecast, by End-use
CHAPTER 8: COMPANY LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Key developments
CHAPTER 9: COMPANY PROFILES
9.1 Adherium
9.1.1 Company overview
9.1.2 Company snapshot
9.1.3 Operating business segments
9.1.4 Product portfolio
9.1.5 Business performance
9.1.6 Key strategic moves and developments
9.2 BD
9.2.1 Company overview
9.2.2 Company snapshot
9.2.3 Operating business segments
9.2.4 Product portfolio
9.2.5 Business performance
9.2.6 Key strategic moves and developments
9.3 Proteus Digital Health
9.3.1 Company overview
9.3.2 Company snapshot
9.3.3 Operating business segments
9.3.4 Product portfolio
9.3.5 Business performance
9.3.6 Key strategic moves and developments
9.4 PROPELLER HEALTH
9.4.1 Company overview
9.4.2 Company snapshot
9.4.3 Operating business segments
9.4.4 Product portfolio
9.4.5 Business performance
9.4.6 Key strategic moves and developments
9.5 F. Hoffmann-La Roche Ltd
9.5.1 Company overview
9.5.2 Company snapshot
9.5.3 Operating business segments
9.5.4 Product portfolio
9.5.5 Business performance
9.5.6 Key strategic moves and developments
9.6 Ypsomed AG
9.6.1 Company overview
9.6.2 Company snapshot
9.6.3 Operating business segments
9.6.4 Product portfolio
9.6.5 Business performance
9.6.6 Key strategic moves and developments
9.7 Cohero Health, Inc.
9.7.1 Company overview
9.7.2 Company snapshot
9.7.3 Operating business segments
9.7.4 Product portfolio
9.7.5 Business performance
9.7.6 Key strategic moves and developments
9.8 West Pharmaceutical Services, Inc.
9.8.1 Company overview
9.8.2 Company snapshot
9.8.3 Operating business segments
9.8.4 Product portfolio
9.8.5 Business performance
9.8.6 Key strategic moves and developments
9.9 Syncro Technology Corp.
9.9.1 Company overview
9.9.2 Company snapshot
9.9.3 Operating business segments
9.9.4 Product portfolio
9.9.5 Business performance
9.9.6 Key strategic moves and developments
9.10 AptarGroup Inc.
9.10.1 Company overview
9.10.2 Company snapshot
9.10.3 Operating business segments
9.10.4 Product portfolio
9.10.5 Business performance
9.10.6 Key strategic moves and developments
LIST OF TABLES
TABLE 1. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
TABLE 2. CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, FOR INJECTABLE, BY REGION, 2021-2030 ($MILLION)
TABLE 3. CONNECTED DRUG DELIVERY DEVICES MARKET FOR INJECTABLE, BY COUNTRY, 2021-2030 ($MILLION)
TABLE 4. CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, FOR INHALATION DEVICES, BY REGION, 2021-2030 ($MILLION)
TABLE 5. CONNECTED DRUG DELIVERY DEVICES MARKET FOR INHALATION DEVICES, BY COUNTRY, 2021-2030 ($MILLION)
TABLE 6. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
TABLE 7. CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, FOR BLUETOOTH, BY REGION, 2021-2030 ($MILLION)
TABLE 8. CONNECTED DRUG DELIVERY DEVICES MARKET FOR BLUETOOTH, BY COUNTRY, 2021-2030 ($MILLION)
TABLE 9. CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, FOR NFC, BY REGION, 2021-2030 ($MILLION)
TABLE 10. CONNECTED DRUG DELIVERY DEVICES MARKET FOR NFC, BY COUNTRY, 2021-2030 ($MILLION)
TABLE 11. CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, FOR OTHERS, BY REGION, 2021-2030 ($MILLION)
TABLE 12. CONNECTED DRUG DELIVERY DEVICES MARKET FOR OTHERS, BY COUNTRY, 2021-2030 ($MILLION)
TABLE 13. GLOBAL CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
TABLE 14. CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, FOR HOMECARE, BY REGION, 2021-2030 ($MILLION)
TABLE 15. CONNECTED DRUG DELIVERY DEVICES MARKET FOR HOMECARE, BY COUNTRY, 2021-2030 ($MILLION)
TABLE 16. CONNECTED DRUG DELIVERY DEVICES MARKET SIZE, FOR HOSPITALS, BY REGION, 2021-2030 ($MILLION)
TABLE 17. CONNECTED DRUG DELIVERY DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2021-2030 ($MILLION)
TABLE 18. CONNECTED DRUG DELIVERY DEVICES MARKET, BY REGION, 2021-2030 ($MILLION)
TABLE 19. NORTH AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
TABLE 20. NORTH AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
TABLE 21. NORTH AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
TABLE 22. NORTH AMERICA CONNECTED DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2021-2030 ($MILLION)
TABLE 23. U.S. CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
TABLE 24. U.S. CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
TABLE 25. U.S. CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
TABLE 26. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
TABLE 27. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
TABLE 28. CANADA CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
TABLE 29. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
TABLE 30. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
TABLE 31. MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
TABLE 32. EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
TABLE 33. EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
TABLE 34. EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
TABLE 35. EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2021-2030 ($MILLION)
TABLE 36. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
TABLE 37. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
TABLE 38. GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
TABLE 39. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
TABLE 40. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
TABLE 41. UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
TABLE 42. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
TABLE 43. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
TABLE 44. FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
TABLE 45. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
TABLE 46. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
TABLE 47. SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
TABLE 48. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
TABLE 49. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
TABLE 50. ITALY CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
TABLE 51. REST OF EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
TABLE 52. REST OF EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
TABLE 53. REST OF EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
TABLE 54. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
TABLE 55. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
TABLE 56. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
TABLE 57. ASIA-PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2021-2030 ($MILLION)
TABLE 58. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
TABLE 59. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
TABLE 60. CHINA CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
TABLE 61. JAPAN CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
TABLE 62. JAPAN CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
TABLE 63. JAPAN CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
TABLE 64. INDIA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
TABLE 65. INDIA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
TABLE 66. INDIA CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
TABLE 67. SOUTH KOREA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
TABLE 68. SOUTH KOREA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
TABLE 69. SOUTH KOREA CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
TABLE 70. AUSTRALIA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
TABLE 71. AUSTRALIA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
TABLE 72. AUSTRALIA CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
TABLE 73. REST OF ASIA PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
TABLE 74. REST OF ASIA PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
TABLE 75. REST OF ASIA PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
TABLE 76. LAMEA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
TABLE 77. LAMEA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
TABLE 78. LAMEA CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
TABLE 79. LAMEA CONNECTED DRUG DELIVERY DEVICES MARKET, BY COUNTRY, 2021-2030 ($MILLION)
TABLE 80. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
TABLE 81. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
TABLE 82. BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
TABLE 83. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
TABLE 84. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
TABLE 85. SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
TABLE 86. UAE CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
TABLE 87. UAE CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
TABLE 88. UAE CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
TABLE 89. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
TABLE 90. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
TABLE 91. SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
TABLE 92. REST OF LAMEA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TYPE, 2021-2030 ($MILLION)
TABLE 93. REST OF LAMEA CONNECTED DRUG DELIVERY DEVICES MARKET, BY TECHNOLOGY, 2021-2030 ($MILLION)
TABLE 94. REST OF LAMEA CONNECTED DRUG DELIVERY DEVICES MARKET, BY END-USE, 2021-2030 ($MILLION)
TABLE 95.ADHERIUM: COMPANY SNAPSHOT
TABLE 96.ADHERIUM: OPERATING SEGMENTS
TABLE 97.ADHERIUM: PRODUCT PORTFOLIO
TABLE 98.ADHERIUM: NET SALES,
TABLE 99.ADHERIUM: KEY STRATERGIES
TABLE 100.BD: COMPANY SNAPSHOT
TABLE 101.BD: OPERATING SEGMENTS
TABLE 102.BD: PRODUCT PORTFOLIO
TABLE 103.BD: NET SALES,
TABLE 104.BD: KEY STRATERGIES
TABLE 105.PROTEUS DIGITAL HEALTH: COMPANY SNAPSHOT
TABLE 106.PROTEUS DIGITAL HEALTH: OPERATING SEGMENTS
TABLE 107.PROTEUS DIGITAL HEALTH: PRODUCT PORTFOLIO
TABLE 108.PROTEUS DIGITAL HEALTH: NET SALES,
TABLE 109.PROTEUS DIGITAL HEALTH: KEY STRATERGIES
TABLE 110.PROPELLER HEALTH: COMPANY SNAPSHOT
TABLE 111.PROPELLER HEALTH: OPERATING SEGMENTS
TABLE 112.PROPELLER HEALTH: PRODUCT PORTFOLIO
TABLE 113.PROPELLER HEALTH: NET SALES,
TABLE 114.PROPELLER HEALTH: KEY STRATERGIES
TABLE 115.F. HOFFMANN-LA ROCHE LTD: COMPANY SNAPSHOT
TABLE 116.F. HOFFMANN-LA ROCHE LTD: OPERATING SEGMENTS
TABLE 117.F. HOFFMANN-LA ROCHE LTD: PRODUCT PORTFOLIO
TABLE 118.F. HOFFMANN-LA ROCHE LTD: NET SALES,
TABLE 119.F. HOFFMANN-LA ROCHE LTD: KEY STRATERGIES
TABLE 120.YPSOMED AG: COMPANY SNAPSHOT
TABLE 121.YPSOMED AG: OPERATING SEGMENTS
TABLE 122.YPSOMED AG: PRODUCT PORTFOLIO
TABLE 123.YPSOMED AG: NET SALES,
TABLE 124.YPSOMED AG: KEY STRATERGIES
TABLE 125.COHERO HEALTH, INC.: COMPANY SNAPSHOT
TABLE 126.COHERO HEALTH, INC.: OPERATING SEGMENTS
TABLE 127.COHERO HEALTH, INC.: PRODUCT PORTFOLIO
TABLE 128.COHERO HEALTH, INC.: NET SALES,
TABLE 129.COHERO HEALTH, INC.: KEY STRATERGIES
TABLE 130.WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT
TABLE 131.WEST PHARMACEUTICAL SERVICES, INC.: OPERATING SEGMENTS
TABLE 132.WEST PHARMACEUTICAL SERVICES, INC.: PRODUCT PORTFOLIO
TABLE 133.WEST PHARMACEUTICAL SERVICES, INC.: NET SALES,
TABLE 134.WEST PHARMACEUTICAL SERVICES, INC.: KEY STRATERGIES
TABLE 135.SYNCRO TECHNOLOGY CORP.: COMPANY SNAPSHOT
TABLE 136.SYNCRO TECHNOLOGY CORP.: OPERATING SEGMENTS
TABLE 137.SYNCRO TECHNOLOGY CORP.: PRODUCT PORTFOLIO
TABLE 138.SYNCRO TECHNOLOGY CORP.: NET SALES,
TABLE 139.SYNCRO TECHNOLOGY CORP.: KEY STRATERGIES
TABLE 140.APTARGROUP INC.: COMPANY SNAPSHOT
TABLE 141.APTARGROUP INC.: OPERATING SEGMENTS
TABLE 142.APTARGROUP INC.: PRODUCT PORTFOLIO
TABLE 143.APTARGROUP INC.: NET SALES,
TABLE 144.APTARGROUP INC.: KEY STRATERGIES
LIST OF FIGURES
FIGURE 1.CONNECTED DRUG DELIVERY DEVICES MARKET SEGMENTATION
FIGURE 2.CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030
FIGURE 3.CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030
FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
FIGURE 5.PORTER FIVE-1
FIGURE 6.PORTER FIVE-2
FIGURE 7.PORTER FIVE-3
FIGURE 8.PORTER FIVE-4
FIGURE 9.PORTER FIVE-5
FIGURE 10.TOP PLAYER POSITIONING
FIGURE 11.CONNECTED DRUG DELIVERY DEVICES MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
FIGURE 12.REGULATORY GUIDELINES
FIGURE 13.VALUE CHAIN ANALYSIS
FIGURE 14.MARKET SHARE ANALYSIS
FIGURE 15.KEY REGULATION ANALYSIS
FIGURE 16.PATENT ANALYSIS BY COMPANY
FIGURE 17.PATENT ANALYSIS BY COUNTRY
FIGURE 18.CONNECTED DRUG DELIVERY DEVICES MARKET,BY TYPE,2021(%)
FIGURE 19.COMPARATIVE SHARE ANALYSIS OF INJECTABLE CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030(%)
FIGURE 20.COMPARATIVE SHARE ANALYSIS OF INHALATION DEVICES CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030(%)
FIGURE 21.CONNECTED DRUG DELIVERY DEVICES MARKET,BY TECHNOLOGY,2021(%)
FIGURE 22.COMPARATIVE SHARE ANALYSIS OF BLUETOOTH CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030(%)
FIGURE 23.COMPARATIVE SHARE ANALYSIS OF NFC CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030(%)
FIGURE 24.COMPARATIVE SHARE ANALYSIS OF OTHERS CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030(%)
FIGURE 25.CONNECTED DRUG DELIVERY DEVICES MARKET,BY END-USE,2021(%)
FIGURE 26.COMPARATIVE SHARE ANALYSIS OF HOMECARE CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030(%)
FIGURE 27.COMPARATIVE SHARE ANALYSIS OF HOSPITALS CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030(%)
FIGURE 28.CONNECTED DRUG DELIVERY DEVICES MARKET BY REGION,2021
FIGURE 29.U.S. CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
FIGURE 30.CANADA CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
FIGURE 31.MEXICO CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
FIGURE 32.GERMANY CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
FIGURE 33.UNITED KINGDOM CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
FIGURE 34.FRANCE CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
FIGURE 35.SPAIN CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
FIGURE 36.ITALY CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
FIGURE 37.REST OF EUROPE CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
FIGURE 38.CHINA CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
FIGURE 39.JAPAN CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
FIGURE 40.INDIA CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
FIGURE 41.SOUTH KOREA CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
FIGURE 42.AUSTRALIA CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
FIGURE 43.REST OF ASIA PACIFIC CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
FIGURE 44.BRAZIL CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
FIGURE 45.SAUDI ARABIA CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
FIGURE 46.UAE CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
FIGURE 47.SOUTH AFRICA CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
FIGURE 48.REST OF LAMEA CONNECTED DRUG DELIVERY DEVICES MARKET,2021-2030($MILLION)
FIGURE 49. TOP WINNING STRATEGIES, BY YEAR
FIGURE 50. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 51. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 52.PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 53.COMPETITIVE DASHBOARD
FIGURE 54.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
FIGURE 55.ADHERIUM.: NET SALES ,($MILLION)
FIGURE 56.BD.: NET SALES ,($MILLION)
FIGURE 57.PROTEUS DIGITAL HEALTH.: NET SALES ,($MILLION)
FIGURE 58.PROPELLER HEALTH.: NET SALES ,($MILLION)
FIGURE 59.F. HOFFMANN-LA ROCHE LTD.: NET SALES ,($MILLION)
FIGURE 60.YPSOMED AG.: NET SALES ,($MILLION)
FIGURE 61.COHERO HEALTH, INC..: NET SALES ,($MILLION)
FIGURE 62.WEST PHARMACEUTICAL SERVICES, INC..: NET SALES ,($MILLION)
FIGURE 63.SYNCRO TECHNOLOGY CORP..: NET SALES ,($MILLION)
FIGURE 64.APTARGROUP INC..: NET SALES ,($MILLION)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security